HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma
Masahiro Shitani(Sapporo Medical University), Hirotoshi Ishiwatari(Shizuoka Cancer Center), Takehiro Abiko(Japanese Red Cross Asahikawa Hospital), Eiichi Tanaka(Yamagata University), Takuma Goto(Asahikawa Medical University), Hiroyuki Maguchi(Teine Keijinkai Hospital), Masayo Motoya(Sapporo Medical University), Yasutoshi Kimura(Sapporo Medical University), Yusuke Sakuhara(Hokkaido University), Hiroshi Kawakami(Hokkaido University Hospital), Junpei Sasajima(Asahikawa Medical College Hospital), Katsuhiko Murakawa(Obihiro Kosei General Hospital), Tsuyoshi Hayashi(National Hospital Organization Hokkaido Medical Center), Shin Haba(Hokkaido hospital), Kakuya Matsumoto(Asahikawa Medical College Hospital), Masafumi Imamura(Sapporo Medical University), Michihiro Ono(Sapporo Medical University), Keisuke Yamakita(Asahikawa Medical University), Nobuyuki Yanagawa, Satoshi Hirano(Hokkaido University of Science), Yohei Kitano(Asahikawa Medical University), Kuniyuki Takahashi(Teine Keijinkai Hospital), Satoshi Tanno(Asahikawa Medical College Hospital), Makoto Omi, Tomoya Iida(University Clinic of Traumatology), Tamaki Sakurai(Muroran Institute of Technology)
Cited by 3
Related Papers
Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines
|Journal of Hepato-Biliary-Pancreatic Surgery|2007|489
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer
|Annals of Surgery|2007|315
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2<sup>nd</sup> English edition
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|300